ClinicalTrials.gov
public full text
Public Domain
Encapsulated Faecal Microbiota Transplantation to Preserve Residual Beta Cell Function in Type 1 Diabetes Mellitus
In this single arm pilot study it will be investigated whether encapsulated autologous fecal microbiota transplantation may be used to halt the decline in residual beta cell function in individuals with recent onset Type 1 diabetes mellitus.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Sensitivity and specificity of tuberculosis screening tools in people with diabetes#243517
- Do People With Complications of Type 1 Diabetes Mellitus Have a Different Microbiome (MARVEL)#158117
- Detection of pancreatic beta cell mass in vivo in humans: studies in individuals with long-standing type 1 diabetes and in individuals with obesity#18841
- Probiotic Supplementation and Pancreatic β-Cell Function in Type 2 Diabetes#387300
- Latent Tuberculosis in Type 2 Diabetes#318557
Record · ID 1046331
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive